Biogen's stock rises 4% after company releases new data on late-stage Alzheimer's drug CNBCAs Alzheimer's Conference Kicks Off, All Eyes Are on Biogen's Drug XconomyNew details emerge on drug that may slow Alzheimer's disease NBCNews.comView full coverage on Google News